SERA News and Press, Sera Prognostics Inc. From 09/14/21

Publication illustrates clinical benefit of combining PreTRM ® testing with evidence-based interventions to improve neonatal health and reduce total health costs Positive impact on preterm births, neonatal intensive care admissions, overall hospital length of stay a...

SALT LAKE CITY, Sept. 13, 2021 (GLOBE NEWSWIRE) -- Sera Prognostics Inc., The Pregnancy Company™ (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced that the com...

This week’s Alpha Trader podcast features hosts Aaron Task and Stephen Alpher talking with George Ball, chairman of Sanders, Morris, Harris. Among the topics discussed: Stocks are expensive and the bull market is long in the tooth, but the Fed (or at least Chairman Jay Powell) is showi...

SALT LAKE CITY, Aug. 30, 2021 (GLOBE NEWSWIRE) -- Sera Prognostics Inc., The Pregnancy Company™ (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced financial res...

Study demonstrates positive impact of the company’s PreTRM ® test and treat strategy on improving neonatal healthcare NICU and total hospital length-of-stay in preemies reduced by more than 70% Faster rate of discharge from the NICU for spontaneous pret...

After a slow start to the month, the IPO market revved back to life with 13 IPOs coming to market this past week. SPAC activity picked up, with seven blank check IPOs raising $940 million. New filers continued to flood the IPO pipeline, with fourteen IPOs and nine SPACs submitting...